An interventional study of pericapsular nerve group and lateral femoral cutaneous nerve block and lumbar plexus block in Post Operative Pain and Regional Block, sponsored by Minia University. Status unknown at 1 site in Egypt. Open to participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-10-19.
Sponsored by Minia University · Not applicable, Interventional, and Prevention
Regional anesthesia for postoperative analgesia in THA includes epidural anesthesia and peripheral nerve blocks. However epidural anesthesia has a great role in THA, it has become restricted as perioperative antithrombotic drugs are generally used for orthopedic patients.
the study aim to evaluate and compare efficacy and safety of pericapsular nerve group block (PENG) block and lateral femoral cutaneous nerve versus Lumbar plexus block on postoperative analgesia in hip surgery.
5,227 studies on the registry are indexed under Pain, Postoperative; 1,154 are open to participants now.
This study's planned enrollment of 66 is below the median of 75 across 4,457 interventional studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →Minia University is the lead sponsor of 369 studies on the registry; 117 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
(ASA) physical status I to III scheduled for hip surgery aged (30-70) years
Exclusion Criteria:
Procedure: pericapsular nerve group and lateral femoral cutaneous nerve block
Procedure: lumbar plexus block
Will undergo pericapsular nerve group block (PENG) combined with lateral femoral cutaneous nerve under ultrasound guided block with 20 mL of 0.25% bupivacaine.
Will undergo Lumbar plexus block (LPB) under ultrasound guided block with 20 mL of 0.25 % bupivacaine.
Visual analogue scale pain scores
pain score from 0-10 which 0 mean no pain and 10 the worst pain
Time frame: 24 hour
first analgesic request
time to demand nalbuphine
Time frame: 24 hour
total analgesic consumption
total nalbuphine in mg consumed in the first day
Time frame: 24 hour
First time to ambulate
first time to move
Time frame: 24 hours
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2023 (actual). Primary completion is estimated for Jan 2024, 12 months after the start.
Of 1,888 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 12 months is close to that.
Counting every sponsor, half of 1,901 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.